Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Quanterix Corp (QTRX)

Quanterix names Anthony Catalano chief operating officer; Michael Miller moves to tech role

Neutral Impact 3 of 5 leadership Written later

Quanterix appointed Anthony Catalano as Chief Operating Officer effective with his May 14, 2026 appointment, under an employment agreement with a $400,000 base salary and a $50,000 sign-on bonus. Former COO Michael Miller moved to the new role of Chief Technology and Products Officer. The change at the top operations post is a leadership change that shareholders may want to follow, but the filing reports no financial results.

Key points

  • Anthony Catalano appointed Chief Operating Officer on May 14, 2026; agreement sets $400,000 base salary, $50,000 sign-on bonus and annual bonus target up to 50% of base salary
  • Catalano received RSUs equal to 0.30% of common shares outstanding on his start date, vesting in four equal annual installments
  • Michael Miller, formerly COO, transitioned to Chief Technology and Products Officer
  • Catalano previously worked at Akoya Biosciences, which Quanterix acquired, from July 2025 to August 2025

The filing

CompanyQuanterix Corp (QTRX)
Form8-K, current report
Filed with the SECMay 26, 2026, 5:25 PM ET
Accession number0001503274-26-000024

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.